Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Alset E Home International Stockholders Equity [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2020			$ 8,570	$ 102,339,666	$ 2,143,338	$ (44,793,713)	$ 59,697,861	$ 37,980,325	$ 97,678,186
Beginning balance, shares at Dec. 31, 2020			8,570,000
Beneficial Conversion Feature Intrinsic Value, Net				50,770,192			50,770,192		50,770,192
Change in Non-Controlling Interest				76,412	(39,067)		37,345	(37,345)
Change in Unrealized Gain on Investment					(1,135)		(1,135)	(852)	(1,987)
Foreign Currency Translations					(1,010,527)		(1,010,527)	(758,913)	(1,769,440)
Net Loss						(6,235,636)	(6,235,636)	(3,569,112)	(9,804,748)
Issuance of Stock for Services			$ 10	60,890			60,900		60,900
Issuance of stock for services , shares
Transactions under Common Control				(57,190,499)			(57,190,499)		(57,190,499)
Sale of Vivacitas to Related Party				2,279,872			2,279,872		2,279,872
Purchase Stock of True Partner from Related Party				3,274,060			3,274,060		3,274,060
Subsidiary’s Issuance of Stock				46,099			46,099	34,677	80,776
Proceeds from Selling Subsidiary Equity				142,675			142,675	107,325	250,000
Distribution to Non-Controlling Shareholders								(82,250)	(82,250)
Ending balance, value at Mar. 31, 2021			$ 8,580	101,799,367	1,092,609	(51,029,349)	51,871,207	33,673,855	85,545,062
Ending balance, shares at Mar. 31, 2021			8,580,000
Beginning balance, value at Dec. 31, 2021			$ 87,368	296,181,977	341,646	(148,233,473)	148,377,518	21,912,268	170,289,786
Beginning balance, shares at Dec. 31, 2021			87,368,446
Issuance of Stock by Exercising Warrants			$ 15,820	(11,925)			3,895		3,895
Issuance of stock by excercising warrants, shares			15,819,452
Convert Related Party Note to Common Stock			$ 10,000	6,203,000			6,213,000		6,213,000
Convert related party note to common stock, shares			10,000,000
Deconsolidate Alset Capital Acquisition				17,160,800			17,160,800	2,227,744	19,388,544
Gain from Purchase of DSS Stock				737,572			737,572		737,572
Beneficial Conversion Feature Intrinsic Value, Net				450,000			450,000		450,000
Change in Non-Controlling Interest				(316,459)	459,069		142,610	(142,610)
Change in Unrealized Gain on Investment					(7,027)		(7,027)	(2,096)	(9,123)
Foreign Currency Translations					(499,967)		(499,967)	(149,173)	(649,140)
Net Loss						(6,467,286)	(6,467,286)	(1,463,167)	(7,930,453)
Transactions under Common Control
Ending balance, value at Mar. 31, 2022			$ 113,188	$ 320,404,965	$ 293,721	$ (154,700,759)	$ 166,111,115	$ 22,382,966	$ 188,494,081
Ending balance, shares at Mar. 31, 2022			113,187,898